• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

作者信息

F Piepoli Massimo

机构信息

Heart Failure Unit, Cardiology Department, Polichirurgico Hospital G. Da Saliceto, Cantone Del Cristo, 29121, Piacenza, Emilia Romagna,, USA.

出版信息

Int J Behav Med. 2017 Jun;24(3):321-419. doi: 10.1007/s12529-016-9583-6.

DOI:10.1007/s12529-016-9583-6
PMID:28290077
Abstract
摘要

相似文献

1
2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会及其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成）
Int J Behav Med. 2017 Jun;24(3):321-419. doi: 10.1007/s12529-016-9583-6.
2
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成），由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Atherosclerosis. 2016 Sep;252:207-274. doi: 10.1016/j.atherosclerosis.2016.05.037.
3
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第六版（由10个学会的代表及特邀专家组成）：由欧洲心血管预防与康复协会（EACPR）提供特别贡献制定而成。
Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709. Epub 2016 Jun 27.
4
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成）由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
5
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].[2016年欧洲临床实践心血管疾病预防指南。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第六版（由10个学会的代表及特邀专家组成。在欧洲心血管预防与康复协会的特别贡献下制定）]
G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612. doi: 10.1714/2729.27821.
6
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)].[《欧洲临床实践心血管疾病预防指南》（2012年版）。欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第五联合工作组（由九个学会的代表和特邀专家组成）]
G Ital Cardiol (Rome). 2013 May;14(5):328-92. doi: 10.1714/1264.13964.
7
European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南（2012年版）》：欧洲心脏病学会及其他学会关于临床实践心血管疾病预防的第五联合工作组（由九个学会的代表及特邀专家组成）
Int J Behav Med. 2012 Dec;19(4):403-88. doi: 10.1007/s12529-012-9242-5.
8
Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology.临床实践中心血管预防更新：欧洲心脏病学会欧洲预防心脏病学协会立场文件。
Eur J Prev Cardiol. 2020 Jan;27(2):181-205. doi: 10.1177/2047487319893035. Epub 2019 Dec 12.
9
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）：欧洲心脏病学会及其他学会临床实践心血管疾病预防联合特别工作组（由九个学会的代表及特邀专家组成）。
Atherosclerosis. 2012 Jul;223(1):1-68. doi: 10.1016/j.atherosclerosis.2012.05.007. Epub 2012 May 14.
10
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）：欧洲心脏病学会及其他学会关于临床实践心血管疾病预防的第五联合工作组（由九个学会的代表及特邀专家组成）
Eur J Prev Cardiol. 2012 Aug;19(4):585-667. doi: 10.1177/2047487312450228. Epub 2012 Jul 4.

引用本文的文献

1
The global burden of aortic aneurysm attributable to hypertension from 1990 to 2021: Current trends and projections for 2050.1990年至2021年高血压所致主动脉瘤的全球负担：当前趋势及2050年预测
PLoS One. 2025 Jul 18;20(7):e0327830. doi: 10.1371/journal.pone.0327830. eCollection 2025.
2
Cardiovascular Nursing in Rehabilitative Cardiology: A Review.康复心脏病学中的心血管护理：综述
J Cardiovasc Dev Dis. 2025 Jun 11;12(6):219. doi: 10.3390/jcdd12060219.
3
Initial co-ideation phase of a shared decision-making tool aimed at promoting physical activity in primary care: views expressed by patients, academics, and healthcare professionals.

本文引用的文献

1
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.阿司匹林用于降低心血管疾病中危患者首发血管事件风险（ARRIVE）的研究：一项随机、双盲、安慰剂对照试验。
Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26.
2
E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis.电子烟在真实世界和临床环境中的戒烟效果：系统评价和荟萃分析。
Lancet Respir Med. 2016 Feb;4(2):116-28. doi: 10.1016/S2213-2600(15)00521-4. Epub 2016 Jan 14.
3
旨在促进初级保健中身体活动的共享决策工具的初始共同构思阶段：患者、学者和医疗保健专业人员表达的观点。
Front Public Health. 2025 May 30;13:1483035. doi: 10.3389/fpubh.2025.1483035. eCollection 2025.
4
Uncovering the Potential Link Between Polychlorinated Biphenyls and Cardiovascular Diseases: A Comprehensive Analysis.揭示多氯联苯与心血管疾病之间的潜在联系：一项综合分析。
Toxics. 2025 Jan 22;13(2):71. doi: 10.3390/toxics13020071.
5
Low KV-low contrast medium dose one-stop dual source CT high pitch integrated coronary-carotid-cerebral-aortic CTA improves image quality and reduces both radiation and contrast medium doses.低千伏-低对比剂剂量一站式双源CT高螺距一体化冠状动脉-颈动脉-脑动脉-主动脉CT血管造影术可提高图像质量，并降低辐射剂量和对比剂剂量。
Eur J Radiol Open. 2025 Jan 29;14:100637. doi: 10.1016/j.ejro.2025.100637. eCollection 2025 Jun.
6
Age Difference in the Connection Between Systemic Inflammatory Response and Metabolic Syndrome.全身炎症反应与代谢综合征之间关联的年龄差异
J Clin Endocrinol Metab. 2025 Feb 18;110(3):634-648. doi: 10.1210/clinem/dgae669.
7
2024 Adult Compendium of Physical Activities: A third update of the energy costs of human activities.2024 年成年人体育活动综合手册：人类活动能量消耗的第三次更新。
J Sport Health Sci. 2024 Jan;13(1):6-12. doi: 10.1016/j.jshs.2023.10.010.
8
Blood pressure measurements for diagnosing hypertension in primary care: room for improvement.血压测量在基层医疗中诊断高血压的应用：仍有改进空间。
BMC Prim Care. 2024 Jan 2;25(1):6. doi: 10.1186/s12875-023-02241-z.
9
Psychometric validity of the Thai version of the Motivation for Healthy Eating Scale in patients with acute coronary syndrome.急性冠状动脉综合征患者中泰语版健康饮食动机量表的心理测量效度
Belitung Nurs J. 2023 Aug 28;9(4):399-405. doi: 10.33546/bnj.2687. eCollection 2023.
10
The Impacts of Animal-Based Diets in Cardiovascular Disease Development: A Cellular and Physiological Overview.动物性饮食对心血管疾病发展的影响：细胞与生理学概述
J Cardiovasc Dev Dis. 2023 Jun 30;10(7):282. doi: 10.3390/jcdd10070282.
Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis.
基于运动的冠心病心脏康复：Cochrane 系统评价和荟萃分析。
J Am Coll Cardiol. 2016 Jan 5;67(1):1-12. doi: 10.1016/j.jacc.2015.10.044.
4
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.利西拉肽治疗 2 型糖尿病合并急性冠状动脉综合征患者的疗效。
N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225.
5
Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome.伐尼克兰用于急性冠状动脉综合征住院患者的戒烟。
Circulation. 2016 Jan 5;133(1):21-30. doi: 10.1161/CIRCULATIONAHA.115.019634. Epub 2015 Nov 9.
6
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
7
Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).根据美国心脏病学会/美国心脏协会胆固醇管理指南，在他汀类药物候选者中进行冠状动脉钙测试的意义：MESA（动脉粥样硬化多民族研究）。
J Am Coll Cardiol. 2015 Oct 13;66(15):1657-68. doi: 10.1016/j.jacc.2015.07.066.
8
Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis.主动、被动和戒烟与 2 型糖尿病发病风险的关系：系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2015 Dec;3(12):958-67. doi: 10.1016/S2213-8587(15)00316-2. Epub 2015 Sep 18.
9
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
10
A Survey of GPs Awareness and Use of Risk Assessment Tools and Cardiovascular Disease Prevention Guidelines.全科医生对风险评估工具及心血管疾病预防指南的认知与使用情况调查
Ir Med J. 2015 Jul-Aug;108(7):204-7.